These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19225549)

  • 61. Engineering chromosomal rearrangements in mice.
    Yu Y; Bradley A
    Nat Rev Genet; 2001 Oct; 2(10):780-90. PubMed ID: 11584294
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Library selection and directed evolution approaches to engineering targeted viral vectors.
    Jang JH; Lim KI; Schaffer DV
    Biotechnol Bioeng; 2007 Oct; 98(3):515-24. PubMed ID: 17614321
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Genome engineering in cattle: recent technological advancements.
    Wang Z
    Chromosome Res; 2015 Feb; 23(1):17-29. PubMed ID: 25596824
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Genetic manipulations in the rat: progress and prospects.
    Huang G; Ashton C; Kumbhani DS; Ying QL
    Curr Opin Nephrol Hypertens; 2011 Jul; 20(4):391-9. PubMed ID: 21546835
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Genetic approaches for changing the heart and dissecting complex syndromes.
    Moga MA; Nakamura T; Robbins J
    J Mol Cell Cardiol; 2008 Aug; 45(2):148-55. PubMed ID: 18601931
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A "mesmer"izing new approach to site-directed mutagenesis in large transformation-ready constructs: Mutagenesis via Serial Small Mismatch Recombineering.
    Jacobs JS; Hong X; Eberl DF
    Fly (Austin); 2011; 5(2):162-9. PubMed ID: 21339708
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The construction of transgenic and gene knockout/knockin mouse models of human disease.
    Doyle A; McGarry MP; Lee NA; Lee JJ
    Transgenic Res; 2012 Apr; 21(2):327-49. PubMed ID: 21800101
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Targeted gene disruption in somatic zebrafish cells using engineered TALENs.
    Sander JD; Cade L; Khayter C; Reyon D; Peterson RT; Joung JK; Yeh JR
    Nat Biotechnol; 2011 Aug; 29(8):697-8. PubMed ID: 21822241
    [No Abstract]   [Full Text] [Related]  

  • 69. Precision gene editing paves way for transgenic monkeys.
    Shen H
    Nature; 2013 Nov; 503(7474):14-5. PubMed ID: 24201259
    [No Abstract]   [Full Text] [Related]  

  • 70. Gene targeting in the rat: advances and opportunities.
    Jacob HJ; Lazar J; Dwinell MR; Moreno C; Geurts AM
    Trends Genet; 2010 Dec; 26(12):510-8. PubMed ID: 20869786
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Heritable gene targeting in zebrafish using customized TALENs.
    Huang P; Xiao A; Zhou M; Zhu Z; Lin S; Zhang B
    Nat Biotechnol; 2011 Aug; 29(8):699-700. PubMed ID: 21822242
    [No Abstract]   [Full Text] [Related]  

  • 72. Protein engineering: navigating between chance and reason.
    Baker M
    Nat Methods; 2011 Jul; 8(8):623-6. PubMed ID: 21799494
    [No Abstract]   [Full Text] [Related]  

  • 73. Genetically modified mouse models in cancer studies.
    Santos J; Fernández-Navarro P; Villa-Morales M; González-Sánchez L; Fernández-Piqueras J
    Clin Transl Oncol; 2008 Dec; 10(12):794-803. PubMed ID: 19068450
    [TBL] [Abstract][Full Text] [Related]  

  • 74. GI GEMs: genetically engineered mouse models of gastrointestinal disease.
    Doetschman T
    Gastroenterology; 2011 Feb; 140(2):380-385.e2. PubMed ID: 21167162
    [No Abstract]   [Full Text] [Related]  

  • 75. Knockout rats generated by embryo microinjection of TALENs.
    Tesson L; Usal C; Ménoret S; Leung E; Niles BJ; Remy S; Santiago Y; Vincent AI; Meng X; Zhang L; Gregory PD; Anegon I; Cost GJ
    Nat Biotechnol; 2011 Aug; 29(8):695-6. PubMed ID: 21822240
    [No Abstract]   [Full Text] [Related]  

  • 76. Knockout punches with a fistful of zinc fingers.
    Wilson JH
    Proc Natl Acad Sci U S A; 2008 Apr; 105(15):5653-4. PubMed ID: 18401029
    [No Abstract]   [Full Text] [Related]  

  • 77. Leverage of nuclease-deficient CasX for preventing pathological angiogenesis.
    Han H; Yang Y; Jiao Y; Qi H; Han Z; Wang L; Dong L; Tian J; Vanhaesebroeck B; Li X; Liu J; Ma G; Lei H
    Mol Ther Nucleic Acids; 2023 Sep; 33():738-748. PubMed ID: 37662968
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Assessment of Mosaicism and Detection of Cryptic Alleles in CRISPR/Cas9-Engineered Neurofibromatosis Type 1 and
    Rubinstein CD; McLean DT; Lehman BP; Meudt JJ; Schomberg DT; Krentz KJ; Reichert JL; Meyer MB; Adams M; Konsitzke CM; Shanmuganayagam D
    Front Genet; 2021; 12():721045. PubMed ID: 34630515
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Engineering animal models of dystonia.
    Oleas J; Yokoi F; DeAndrade MP; Pisani A; Li Y
    Mov Disord; 2013 Jun; 28(7):990-1000. PubMed ID: 23893455
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Performance of computational tools in evaluating the functional impact of laboratory-induced amino acid mutations.
    Gray VE; Kukurba KR; Kumar S
    Bioinformatics; 2012 Aug; 28(16):2093-6. PubMed ID: 22685075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.